AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Immunity and immunosuppression in visceral leishmaniasis reviewed.

Vaccine Weekly

| July 07, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 JUL 7 - (NewsRx.com & NewsRx.net) -- Scientists review immunity and immunosuppression in experimental visceral leishmaniasis in a recent issue of the Brazilian Journal of Medical and Biological Research.

"Leishmaniasis is a disease caused by protozoa of the genus Leishmania, and visceral leishmaniasis is a form in which the inner organs are affected. Since knowledge about immunity in experimental visceral leishmaniasis is poor, we present here a review on immunity and immunosuppression in experimental visceral leishmaniasis in mouse and hamster models. We show the complexity of the mechanisms involved and differences when compared with the cutaneous form of leishmaniasis," researchers in Brazil report.

"Resistance in visceral leishmaniasis involves both CD4+ and CD8+ T cells, and interleukin (IL)-2, interferon (IFN)-gamma, and IL-12, the latter in a mechanism independent of IFN-gamma and linked to transforming growth factor (TGF)-beta production," said H. Goto and J. A. L. Lindoso at the University of Sao Paulo. "Susceptibility involves IL-10 but not IL-4, and B cells. In immune animals, upon re-infection, the elements involved in resistance are different, i.e., CD8+ T cells and IL-2. Since one of the immunopathological consequences of active visceral leishmaniasis in humans is suppression of T-cell responses, many studies have been conducted using experimental models."

"Immunosuppression is mainly Leishmania antigen specific, and T cells, Th2 cells, and adherent antigen-presenting cells have been shown to be involved," stated the ...

Related articles from newspapers, magazines, journals, and more
Visceral leishmaniasis treatment, Italy.(Dispatches)
Magazine article from: Emerging Infectious Diseases Gradoni, Luigi Gramiccia, Marina Scalone, Aldo December 1, 2003 700+ words
...immuno-competent patients with visceral leishmaniasis in Italy. In the past 12 years...Zoonotic visceral leishmaniasis is a life-threatening disease...first half of the 20th century, visceral leishmaniasis was a typical infantile syndrome...
Independent investigators declare AmBisome "optimal regimen" for visceral...
Press release article from: Business Wire June 27, 1996 700+ words
...nontoxic form of treatment for (visceral leishmaniasis) when administered in a short...with conventional treatment for visceral leishmaniasis," said the study's authors...56 children and 32 adults with visceral leishmaniasis, a parasitic disease common in...
Visceral Leishmaniasis Relapses: Don't Lose HAART.
Newspaper article from: Travel Medicine Advisor June 1, 2004 700+ words
Visceral Leishmaniasis Relapses: Dont Lose HAART...patients with relapses of visceral leishmaniasis have higher levels of HIV...JA, et al. Frequency of visceral leishmaniasis relapses in Human Immunodeficiency...
First report of visceral leishmaniasis?: case report
Magazine article from: Reactions Weekly Anonymous August 16, 2008 700+ words
...A 37-year-old man developed visceral leishmaniasis during treatment with peginterferon...antibody test. He was diagnosed with visceral leishmaniasis; at this stage he appeared severely...there had been no relapse of visceral leishmaniasis. Author comment: "A higher susceptibility...
Changing pattern of visceral leishmaniasis, United Kingdom,...
Magazine article from: Emerging Infectious Diseases Malik, Aeesha N.J. John, Lawrence Bryceson, Anthony D.M. Lockwood, Diana N.J. August 1, 2006 700+ words
...review of 39 patients with imported visceral leishmaniasis found that tourism to Mediterranean...infection were associated with visceral leishmaniasis. Diagnosis was often delayed...amphotericin B has improved prognosis. Visceral leishmaniasis should be made a reportable disease...
Canine visceral leishmaniasis, United States and Canada, 2000-2003.(RESEARCH)
Magazine article from: Emerging Infectious Diseases Duprey, Zandra H. Steurer, Francis J. Rooney, Jane A. Kirchhoff, Louis V. Jackson, Joan E. Rowton, Edgar D. Schantz, Peter M. March 1, 2006 700+ words
Visceral leishmaniasis, caused by protozoa of the...increased. ********** Visceral leishmaniasis, caused by geographic variants...humans (6). Until recently, visceral leishmaniasis was thought to be primarily...
Asymptomatic visceral leishmaniasis, northern Israel. (Dispatches).
Magazine article from: Emerging Infectious Diseases Adini, Irit Ephros, Moshe Chen, Jacopo Jaffe, Charles L. March 1, 2003 700+ words
Asymptomatic human visceral leishmaniasis was identified in Israel...were more prevalent in visceral leishmaniasis--endemic (2.97...Human visceral leishmaniasis (HVL), caused by the...
Efalizumab: First report of visceral leishmaniasis: case report
Magazine article from: Reactions Weekly Anonymous December 6, 2008 700+ words
...old man developed visceral leishmaniasis while receiving efalizumab...Gallo L, Ayala F. Visceral leishmaniasis infection in a patient...previous case reports of visceral leishmaniasis associated with efalizumab...
For more facts and information, see all results

Source: HighBeam Research, Immunity and immunosuppression in visceral leishmaniasis reviewed.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA